Stay updated on Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page
- Check6 days agoChange DetectedNo additions or deletions are present. The content appears unchanged relative to the captured data.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page’s version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a new site release. No changes to the underlying study content are reflected.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page now shows revision v3.5.2 and no longer lists v3.5.0.SummaryDifference0.1%

- Check28 days agoChange DetectedPublications section updated: added the 2026 Int J Cancer paper on TP53 mutation and removed the earlier Int J Cancer entry.SummaryDifference0.1%

- Check49 days agoChange DetectedThe site revision label in the footer has been updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a Publications subsection including the Int J Cancer article on TP53 mutation and cetuximab/pembrolizumab. Noted that publications are automatically filled from PubMed.SummaryDifference0.3%

Stay in the know with updates to Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.